Answers are grounded in this paper and cite their sources.
) dorsal corticospinal tract (CST) transection model for assessing the tumorigenicity of human cell-based therapeutics. Due to a lack of published historical data for this strain, we analyzed the histopathological profile of Sham Control (n = 56) and Positive Control (n = 16; transplanted with undifferentiated induced pluripotent stem cells) cohorts over the course of 39 weeks. Sham and/or Positive Control animals, subjected to laminectomy and CST transection at the cervical region, exhibited procedure-related reactive changes-including necrosis, cavitation, and gliosis-while demonstrating the strain's spontaneous, age-related background pathology, such as incidental pituitary adenomas, mammary gland fibroadenoma, and systemic malignant lymphomas. These baseline data are essential for accurately distinguishing spontaneous lesions from potential test-item-associated toxicity. The Positive Control group confirmed the model's high sensitivity, showing consistent teratoma formation at the CST transection site in both surviving and unscheduled decedents, with Ku80 immunohistochemical labeling verifying the human xenograft origin of the tumors. Our results demonstrate that this model is a robust, sensitive platform for evaluating the tumorigenic potential of pluripotent stem cell-based therapies, providing a necessary pathological foundation for distinguishing between procedural trauma, incidental background lesions, and true neoplastic development in future preclinical safety studies.
No takes yet. Share an insight, caveat, or question.
Ramot et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: